Matches in SemOpenAlex for { <https://semopenalex.org/work/W174473018> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W174473018 endingPage "702" @default.
- W174473018 startingPage "S" @default.
- W174473018 abstract "Introduction: As the childhood obesity epidemic grows, an increasing number of children are diagnosed with non-alcoholic fatty liver disease (NAFLD) and type 2 non-alcoholic steatohepatitis (NASH). One common finding in NASH patients is increased levels of free fatty acids (FFA). Peroxidation of FFA by reactive oxygen species (ROS) has been shown to cause damage to cellular membranes and organelles such as mitochondria. Studies in humans and animals have demonstrated that oxidative stress, which produces ROS, is a critical player in the pathogenesis of NASH. PON1 is an enzyme exclusively synthesized in the liver and functions as an antioxidant preventing the oxidation of High Density Lipoproteins (HDL). Studies in adults have shown comparable activity of PON1 in both liver and serum, thus making it a potential biomarker for evaluating liver disease. Adult human and animal studies have demonstrated decreased or depleted PON1 activity with diseased liver architecture and changes in plasma lipoprotein subclass distribution. This can lead to increased production of oxidative stress and subsequent atherosclerotic risk. Currently the relationships between PON1 and pediatric (type 2) NASH, is unknown. This study focuses on the gene expression of PON1 in type 2 NASH. Methods and Results: NASH was diagnosed according to Kleiner's criteria. Data mining on NASH microarray database [1] showed a difference in the relative expression of PON1 among insulin resistant (1.77x) and non insulin resistant (2.24x) pediatric NASH patients compared to normal controls (NC). Additional quantitative analysis of the PON1 expression in liver tissue of NASH (n=18) and NC (n= 4) with GAPDH as the housekeeping gene was performed with real time PCR. PON1 mRNA expression level was found to be 8.18 times that of the NC (p< 0.005). Conclusion: The increase in the expression of PON1 in pediatric NASH livers suggests a shift in the balance between antioxidants and oxidative stress. This finding is in contrast to adult NASH studies where a decreased level of PON1 activity in serum was reported with NASH type I. Our findings suggest that the hepatic damage involved in type 2 NASH is not as extensive compared to the hepatic damage noted in type 1 NASH. In addition this data suggests that serum levels of PON1 are likely inadequate surrogate for liver biopsy when assessing pediatric liver disease, additional studies are necessary." @default.
- W174473018 created "2016-06-24" @default.
- W174473018 creator A5007350969 @default.
- W174473018 creator A5028419637 @default.
- W174473018 creator A5038464428 @default.
- W174473018 creator A5056986765 @default.
- W174473018 creator A5078304171 @default.
- W174473018 date "2011-05-01" @default.
- W174473018 modified "2023-10-18" @default.
- W174473018 title "Elevated Paraoxonase 1 (PON1) Activity in Pediatric Non-Alcoholic Steatohepatitis (NASH) Livers" @default.
- W174473018 doi "https://doi.org/10.1016/s0016-5085(11)62916-8" @default.
- W174473018 hasPublicationYear "2011" @default.
- W174473018 type Work @default.
- W174473018 sameAs 174473018 @default.
- W174473018 citedByCount "0" @default.
- W174473018 crossrefType "journal-article" @default.
- W174473018 hasAuthorship W174473018A5007350969 @default.
- W174473018 hasAuthorship W174473018A5028419637 @default.
- W174473018 hasAuthorship W174473018A5038464428 @default.
- W174473018 hasAuthorship W174473018A5056986765 @default.
- W174473018 hasAuthorship W174473018A5078304171 @default.
- W174473018 hasBestOaLocation W1744730181 @default.
- W174473018 hasConcept C104317684 @default.
- W174473018 hasConcept C126322002 @default.
- W174473018 hasConcept C135763542 @default.
- W174473018 hasConcept C185592680 @default.
- W174473018 hasConcept C2776151105 @default.
- W174473018 hasConcept C2776509667 @default.
- W174473018 hasConcept C2778772119 @default.
- W174473018 hasConcept C2779134260 @default.
- W174473018 hasConcept C2779478299 @default.
- W174473018 hasConcept C37501387 @default.
- W174473018 hasConcept C55493867 @default.
- W174473018 hasConcept C71924100 @default.
- W174473018 hasConcept C90924648 @default.
- W174473018 hasConceptScore W174473018C104317684 @default.
- W174473018 hasConceptScore W174473018C126322002 @default.
- W174473018 hasConceptScore W174473018C135763542 @default.
- W174473018 hasConceptScore W174473018C185592680 @default.
- W174473018 hasConceptScore W174473018C2776151105 @default.
- W174473018 hasConceptScore W174473018C2776509667 @default.
- W174473018 hasConceptScore W174473018C2778772119 @default.
- W174473018 hasConceptScore W174473018C2779134260 @default.
- W174473018 hasConceptScore W174473018C2779478299 @default.
- W174473018 hasConceptScore W174473018C37501387 @default.
- W174473018 hasConceptScore W174473018C55493867 @default.
- W174473018 hasConceptScore W174473018C71924100 @default.
- W174473018 hasConceptScore W174473018C90924648 @default.
- W174473018 hasIssue "5" @default.
- W174473018 hasLocation W1744730181 @default.
- W174473018 hasOpenAccess W174473018 @default.
- W174473018 hasPrimaryLocation W1744730181 @default.
- W174473018 hasRelatedWork W172225683 @default.
- W174473018 hasRelatedWork W2036698572 @default.
- W174473018 hasRelatedWork W2157901606 @default.
- W174473018 hasRelatedWork W2218554819 @default.
- W174473018 hasRelatedWork W2392754536 @default.
- W174473018 hasRelatedWork W2783108461 @default.
- W174473018 hasRelatedWork W2965259307 @default.
- W174473018 hasRelatedWork W3091117656 @default.
- W174473018 hasRelatedWork W3152067113 @default.
- W174473018 hasRelatedWork W4312196341 @default.
- W174473018 hasVolume "140" @default.
- W174473018 isParatext "false" @default.
- W174473018 isRetracted "false" @default.
- W174473018 magId "174473018" @default.
- W174473018 workType "article" @default.